|
Market Closed -
NYSE
04:00:02 2026-09-24 pm EDT
|
5-day change | 1st Jan Change | ||
| 25.06 USD | -5.04% |
|
+1.66% | +5.16% |
| Sep. 16 | TD Cowen Initiates Arcus Biosciences at Buy | MT |
| Sep. 15 | Arcus Biosciences, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 12:20 PM |
| Market Cap | 3.36B 2.95B 2.78B 2.54B 4.75B 322B 4.79B 33.31B 12.92B 164B 12.62B 12.34B 534B | P/E 2026 * |
-7.38x | P/E 2027 * | -7.31x |
|---|---|---|---|---|---|
| Enterprise Value | 2.92B 2.57B 2.42B 2.21B 4.13B 280B 4.16B 28.94B 11.23B 143B 10.96B 10.72B 464B | EV / Sales 2026 * |
37.5x | EV / Sales 2027 * | 63.9x |
| Free-Float |
71.2% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| RCUS | Delayed | |
CBOE
| RCUS | Real-time |
Last Transcript: Arcus Biosciences, Inc.
| 1 day | -5.04% | ||
| 1 week | +1.66% | ||
| Current month | -14.41% | ||
| 1 month | -17.40% | ||
| 3 months | -11.07% | ||
| 6 months | +17.05% | ||
| Current year | +5.16% |
| 1 week | 24.42 |  | 27.9 |
| 1 month | 23.31 | | 31.58 |
| Current year | 18.52 | | 31.74 |
| 1 year | 12.15 | | 31.74 |
| 3 years | 6.5 | | 31.74 |
| 5 years | 6.5 | | 49.1 |
| 10 years | 6.3 | | 49.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Juan Jaen
PSD | President | 68 | 2015-04-30 |
Terry Rosen
CEO | Chief Executive Officer | 67 | 2015-04-30 |
Robert Goeltz
DFI | Director of Finance/CFO | 53 | 2020-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Terry Rosen
CHM | Chairman | 67 | 2017-11-30 |
Kathryn Falberg
BRD | Director/Board Member | 65 | 2017-09-17 |
Yasunori Kaneko
BRD | Director/Board Member | 72 | 2015-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/21/26 | Exercice | Controller/Auditor | 8,481 | 0.0067% | ||
| 7/10/26 | Sell | Founder | -20,067 | 0.0160% | ||
| 6/11/26 | Free | Director | 22,600 | 0.0180% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.04% | +1.66% | +102.26% | +27.08% | 3.36B | |
| +1.46% | +5.87% | +5.75% | +33.71% | 47.56B | |
| +2.67% | +2.31% | +47.50% | +38.37% | 44.09B | |
| -1.38% | +3.42% | +9.39% | +88.88% | 41.5B | |
| +4.78% | +2.01% | +352.12% | +566.20% | 40.88B | |
| -0.62% | +0.11% | +1.12% | +46.02% | 29.67B | |
| +0.56% | +0.67% | +25.08% | +155.71% | 17.23B | |
| +2.05% | +4.04% | +24.47% | +41.67% | 15.06B | |
| +3.39% | -6.86% | - | - | 14.65B | |
| +7.38% | +17.54% | -2.25% | - | 13.82B | |
| Average | +0.39% | +1.33% | +62.83% | +124.71% | 26.78B | |
| Weighted average by Cap. | +0.87% | +1.04% | +72.28% | +145.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 77.89M 68.46M 64.49M 58.94M 110M 7.47B 111M 772M 299M 3.81B 292M 286M 12.37B | 50.98M 44.81M 42.21M 38.58M 72.09M 4.89B 72.71M 505M 196M 2.49B 191M 187M 8.09B |
| Net income | -451M -396M -373M -341M -638M -43.26B -643M -4.47B -1.73B -22.04B -1.69B -1.66B -71.59B | -454M -399M -376M -343M -642M -43.55B -647M -4.5B -1.75B -22.18B -1.7B -1.67B -72.07B |
| Net Debt | -441M -387M -365M -333M -623M -42.28B -629M -4.37B -1.69B -21.54B -1.65B -1.62B -69.97B | -102M -89.79M -84.58M -77.3M -144M -9.8B -146M -1.01B -393M -4.99B -384M -375M -16.22B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | $25.06 | -5.04% | 1,992,778 |
| 26-09-23 | $26.39 | -1.79% | 1,561,371 |
| 26-09-22 | $26.87 | +3.55% | 1,385,299 |
| 26-09-21 | $25.95 | +2.81% | 1,111,194 |
| 26-09-18 | $25.24 | -1.17% | 2,897,087 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RCUS Stock
Select your edition
All financial news and data tailored to specific country editions
